Mutual of America Capital Management LLC Has $23.45 Million Position in Danaher Corporation $DHR

Mutual of America Capital Management LLC grew its stake in Danaher Corporation (NYSE:DHR) by 7.3% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 102,428 shares of the conglomerate’s stock after purchasing an additional 6,985 shares during the period. Mutual of America Capital Management LLC’s holdings in Danaher were worth $23,448,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently made changes to their positions in the stock. JPL Wealth Management LLC acquired a new position in shares of Danaher in the 3rd quarter worth approximately $25,000. Elevated Capital Advisors LLC acquired a new position in shares of Danaher in the 4th quarter worth approximately $26,000. WFA of San Diego LLC acquired a new position in shares of Danaher in the 2nd quarter worth approximately $26,000. ANTIPODES PARTNERS Ltd acquired a new position in shares of Danaher in the 3rd quarter worth approximately $27,000. Finally, Financial Life Planners acquired a new position in shares of Danaher in the 3rd quarter worth approximately $32,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on DHR shares. Weiss Ratings reiterated a “hold (c)” rating on shares of Danaher in a research note on Friday, March 27th. JPMorgan Chase & Co. lowered their price objective on shares of Danaher from $275.00 to $245.00 and set an “overweight” rating for the company in a research note on Wednesday, April 22nd. Barclays lowered their price objective on shares of Danaher from $250.00 to $230.00 and set an “overweight” rating for the company in a research note on Tuesday, April 14th. Rothschild & Co Redburn set a $205.00 price objective on shares of Danaher in a research note on Friday, April 17th. Finally, Evercore lifted their price objective on shares of Danaher from $225.00 to $232.00 and gave the company an “outperform” rating in a research note on Tuesday, April 21st. Nineteen research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $238.24.

Danaher Stock Performance

Shares of DHR opened at $180.07 on Tuesday. Danaher Corporation has a 1 year low of $160.93 and a 1 year high of $242.80. The stock’s fifty day moving average price is $181.91 and its two-hundred day moving average price is $207.20. The firm has a market cap of $127.45 billion, a PE ratio of 34.83, a PEG ratio of 2.44 and a beta of 0.81. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.87 and a quick ratio of 1.52.

Danaher (NYSE:DHR) last released its quarterly earnings data on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, beating the consensus estimate of $1.94 by $0.12. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The business had revenue of $5.95 billion for the quarter, compared to the consensus estimate of $6 billion. During the same period in the prior year, the firm earned $1.88 earnings per share. The company’s revenue was up 3.7% compared to the same quarter last year. On average, equities research analysts forecast that Danaher Corporation will post 8.43 EPS for the current year.

Danaher Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be paid a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s dividend payout ratio (DPR) is currently 30.95%.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.